Predict your next investment

Gedea Biotech company logo
HEALTHCARE | Biotechnology
gedeabiotech.com

See what CB Insights has to offer

Total Raised

$290K

Investors Count

3

Gedea Biotech Funding, Gedea Biotech Valuation & Gedea Biotech Revenue

2 Fundings

Gedea Biotech's latest funding round was a Grant for $0.05M on October 26, 2018.

Date

Round

Amount

Investors

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Revenue

Sources

10/26/2018

Grant

$0.05M

$0.00B

((9.99x))

FY 1234

1

12/22/2017

Unattributed VC

$99M

$0.00B

((9.99x))

FY 1234

10

Date

10/26/2018

12/22/2017

Round

Grant

Unattributed VC

Amount

$0.05M

$99M

Investors

Valuation

Revenue

$0.00B

((9.99x))

FY 1234

$0.00B

((9.99x))

FY 1234

Sources

1

10

Gedea Biotech Investors

3 Investors

Gedea Biotech has 3 investors. Horizon 2020 invested in Gedea Biotech's Grant funding round.

First funding

Last Funding

Investor

Rounds

Board Seats

Type

Location

10/26/2018

10/26/2018

1
Grant

Government

Belgium

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

Venture Capital

Sweden

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

Venture Capital

Sweden

First funding

10/26/2018

00/00/0000

00/00/0000

Last Funding

10/26/2018

00/00/0000

00/00/0000

Investor

Subscribe to see more

Subscribe to see more

Rounds

1
Grant

Subscribe to see more

Subscribe to see more

Board Seats

Subscribe to see more

Subscribe to see more

Type

Government

Venture Capital

Venture Capital

Location

Belgium

Sweden

Sweden

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.